Table I.
Therapeutic method | Mechanisms of antipruritic effects |
---|---|
Topical treatment | |
Emollients | • Reduction in epidermal nerve density |
• hydrophilic petrolatum, heparinoid cream, gel-like moisturizing lotion | |
Film dressings | • Reduction in epidermal nerve density • Prevention of mechanical stimulus |
Phototherapy | • Normalization of expression levels of nerve elongation factors and nerve repulsion factors |
• Psoralen ultraviolet A | ⇨ Reduction in epidermal nerve density |
• Narrowband ultraviolet B | • Induction of cutaneous nerve degeneration |
• Excimer lamp | |
Systemic treatment | |
Neurotropin | • Reduction in epidermal nerve density |
μ-receptor antagonist & κ-opioid agonist | • μ-receptor antagonist and κ-opioid agonist in the central nervous system |
Collagen tripeptide | • Reduction in epidermal nerve density, normalization of axon-guidance factors |
Antioxidants | • Inhibition of oxidative stress in the periphery |
Fish oil | • Improvement of skin barrier function |
Adjunctive treatment | |
Second generation of H1-antihistamines, e.g. bepotastine | • Reduction in nerve elongation factors and epidermal hyperplasia |